Meeting
2021 ASCO Annual Meeting
Neoadjuvant chemotherapy to improve colon cancer survival in resectable metastatic colon cancer: A real world NCDB data analysis.
Authors
Saurabh Parasramka
University of Kentucky, Lexington, KY
Saurabh Parasramka , Aasems Jacob , Quan Chen , Bin Huang , Zhonglin Hao
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 3567)
DOI
10.1200/JCO.2021.39.15_suppl.3567
Abstract #
3567
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Pelvic radiotherapy in combination with radical resection of the primary tumor improves survival in patients with metastatic rectal adenocarcinoma: A national cancer database analysis (NCDB).
First Author: Paul B. Renz
Poster
2013 Gastrointestinal Cancers Symposium
Association of increased survival with surgery and radiation therapy in metastatic gastric cancer: A SEER database analysis.
First Author: Ravi Shridhar
Poster
2024 ASCO Annual Meeting
Survival and patient-reported outcomes of real-world patients with high-risk stage II and stage III colon cancer after 3 versus 6 months of adjuvant CAPOX.
First Author: Ingrid A. Franken
Poster
2024 ASCO Annual Meeting
Ten-year outcomes of targeted axillary surgery after neoadjuvant chemotherapy in breast cancer.
First Author: Jeeyeon Lee